Propionate inhibits the MAPK signaling pathway and prevents proliferation of CRC cells (Davido et al., 2001), while acetate dramatically reduces production of pro-inflammatory agents via inhibition of NF-κB signaling pathway in CRC cells, inhibiting the cancer progression. Here, NFKB1 is linked to colorectal carcinoma.